01 1Sun Pharmaceutical Industries Limited
01 1TADALAFIL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-08-24
Pay. Date : 2015-04-28
DMF Number : 29316
Submission : 2015-06-24
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL USP, with a corresponding US DMF Number 29316.
Remarkably, this DMF maintains an Active status since its submission on June 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 24, 2015, and payment made on April 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
